Cita APA

Varghese, L., Talbot, L., Govender, A., Zhang, X., & Mungall, B. A. (2018). A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand. Appl Health Econ Health Policy.

Chicago Style Citation

Varghese, Lijoy, Louise Talbot, Andrea Govender, Xu-Hao Zhang, i Bruce A. Mungall. "A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand." Appl Health Econ Health Policy 2018.

Cita MLA

Varghese, Lijoy, et al. "A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand." Appl Health Econ Health Policy 2018.